Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Merck
Queensland Health
Farmers Insurance
Fish and Richardson
Medtronic

Generated: June 17, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: NIACIN

« Back to Dashboard

NIACIN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Amneal Pharms NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 203578 ANDA Marlex Pharmaceuticals Inc 10135-612-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (10135-612-05)
Amneal Pharms NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 203578 ANDA Marlex Pharmaceuticals Inc 10135-612-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (10135-612-30)
Amneal Pharms NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 203578 ANDA Marlex Pharmaceuticals Inc 10135-612-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (10135-612-90)
Amneal Pharms NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 203578 ANDA Marlex Pharmaceuticals Inc 10135-613-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (10135-613-05)
Amneal Pharms NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 203578 ANDA Marlex Pharmaceuticals Inc 10135-613-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (10135-613-30)
Amneal Pharms NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 203578 ANDA Marlex Pharmaceuticals Inc 10135-613-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (10135-613-90)
Amneal Pharms NIACIN niacin TABLET, EXTENDED RELEASE;ORAL 203578 ANDA Marlex Pharmaceuticals Inc 10135-614-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (10135-614-05)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Teva
Merck
AstraZeneca
US Department of Justice
Mallinckrodt